{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T23:51:58Z","timestamp":1716421918242},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,2,2]],"date-time":"2011-02-02T00:00:00Z","timestamp":1296604800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s12098-010-0312-x","type":"journal-article","created":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T08:50:04Z","timestamp":1296550204000},"page":"826-832","source":"Crossref","is-referenced-by-count":17,"title":["Transient Myeloproliferative Disorder and GATA1 Mutation in Neonates With and Without Down Syndrome"],"prefix":"10.1007","volume":"78","author":[{"given":"Ming-Horng","family":"Tsai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Woei","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao-Ping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pong-Hong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Ming","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jen-Fu","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Chou","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsuan-Rong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,2,2]]},"reference":[{"key":"312_CR1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/pbc.20141","volume":"44","author":"GV Massey","year":"2005","unstructured":"Massey GV. Transient leukemia in newborns with Down syndrome. Pediatr Blood Cancer. 2005;44:29\u201332.","journal-title":"Pediatr Blood Cancer"},{"key":"312_CR2","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1001\/jama.1954.73690210004006b","volume":"155","author":"GJ Schunk","year":"1954","unstructured":"Schunk GJ, Lehman WL. Mongolism and congenital leukemia. JAMA. 1954;155:250\u20131.","journal-title":"JAMA"},{"key":"312_CR3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0022-3476(64)80535-7","volume":"65","author":"R Engel","year":"1964","unstructured":"Engel R, Hammond D. Transient congenital leukemia in 7 infants with mongolism. J Pediatr. 1964;65:303\u20135.","journal-title":"J Pediatr"},{"key":"312_CR4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/01.mph.0000151801.26478.03","volume":"27","author":"IQ Magalh\u00e3es","year":"2005","unstructured":"Magalh\u00e3es IQ, Splendore A, Emerenciano M, et al. Transient neonatal myeloproliferative disorder without Down syndrome and detection of GATA1 mutation. J Pediatr Hematol Oncol. 2005;27:50\u20132.","journal-title":"J Pediatr Hematol Oncol"},{"key":"312_CR5","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jpeds.2005.12.031","volume":"148","author":"T Cushing","year":"2006","unstructured":"Cushing T, Clericuzio CL, Wilson CS, et al. Risk for leukemia in infants without Down syndrome who have transient myeloproliferative disorder. J Pediatr. 2006;148:687\u20139.","journal-title":"J Pediatr"},{"key":"312_CR6","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/ajh.2830470413","volume":"47","author":"MD Brissette","year":"1994","unstructured":"Brissette MD, Duval-Arnould BJ, Gordon BG, Cotelingam JD. Acute megakaryoblastic leukemia following transient myeloproliferative disorder in a patient without Down syndrome. Am J Hematol. 1994;47:316\u20139.","journal-title":"Am J Hematol"},{"key":"312_CR7","doi-asserted-by":"crossref","first-page":"F215","DOI":"10.1136\/fn.79.3.F215","volume":"79","author":"M Richards","year":"1998","unstructured":"Richards M, Welch J, Watmore A, Readett D, Vora AJ. Trisomy 21 associated transient neonatal myeloproliferation in the absence of Down\u2019s syndrome. Arch Dis Child Fetal Neonatal Ed. 1998;79:F215\u2013217.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"312_CR8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/pbc.20066","volume":"44","author":"JD Crispino","year":"2005","unstructured":"Crispino JD. GATA1 mutations in Down syndrome: implications for biology and diagnosis of children with transient myeloproliferative disorder and acute megakaryoblastic leukemia. Pediatr Blood Cancer. 2005;44:40\u20134.","journal-title":"Pediatr Blood Cancer"},{"key":"312_CR9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/01.mph.0000159934.35079.b5","volume":"27","author":"A Gassas","year":"2005","unstructured":"Gassas A, Doyle JJ, Weitzman S, et al. A basic classification and a comprehensive pediatric myeloproliferative disorder. J Pediatr Hematol Oncol. 2005;27:192\u20136.","journal-title":"J Pediatr Hematol Oncol"},{"key":"312_CR10","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1182\/blood-2005-06-2448","volume":"107","author":"GV Massey","year":"2006","unstructured":"Massey GV, Zipursky A, Chang MN, et al. A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): a Children\u2019s Oncology Group (COG) study POG-9481. Blood. 2006;107:4606\u201313.","journal-title":"Blood"},{"key":"312_CR11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/MOP.0b013e328013e7b2","volume":"19","author":"P Vyas","year":"2007","unstructured":"Vyas P, Crispino JD. Molecular insights into Down syndrome-associated leukemia. Curr Opin Pediatr. 2007;19:9\u201314.","journal-title":"Curr Opin Pediatr"},{"key":"312_CR12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.bcmd.2003.08.001","volume":"31","author":"ME Greene","year":"2003","unstructured":"Greene ME, Mundschau G, Wechsler J, et al. Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome. Blood Cells Mol Dis. 2003;31:351\u20136.","journal-title":"Blood Cells Mol Dis"},{"key":"312_CR13","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1182\/blood-2003-10-3383","volume":"103","author":"M Ahmed","year":"2004","unstructured":"Ahmed M, Sternberg A, Hall G, et al. Natural history of GATA1 mutations in Down syndrome. Blood. 2004;103:2480\u20139.","journal-title":"Blood"},{"key":"312_CR14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0272-2712(18)30133-1","volume":"19","author":"A Zipursky","year":"1999","unstructured":"Zipursky A, Brown EJ, Christensen H, Doyle J. Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome. Clin Lab Med. 1999;19:157\u201367.","journal-title":"Clin Lab Med"},{"key":"312_CR15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(99)05264-2","volume":"355","author":"H Hasle","year":"2000","unstructured":"Hasle H, Clemmensen IH, Mikkelsen M. Risks of leukemia and solid tumors in individuals with Down\u2019s syndrome. Lancet. 2000;355:165\u20139.","journal-title":"Lancet"},{"key":"312_CR16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/pbc.20141","volume":"44","author":"GV Massey","year":"2005","unstructured":"Massey GV. Transient leukemia in newborns with Down syndrome. Pediatr Blood Cancer. 2005;44:29\u201332.","journal-title":"Pediatr Blood Cancer"},{"key":"312_CR17","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/01.pap.0000213039.93328.44","volume":"13","author":"DS Brink","year":"2006","unstructured":"Brink DS. Transient leukemia (transient myeloproliferative disorder, transient abnormal myelopoiesis) of Down syndrome. Adv Anat Pathol. 2006;13:256\u201362.","journal-title":"Adv Anat Pathol"},{"key":"312_CR18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0146-0005(97)80025-0","volume":"21","author":"A Zipursky","year":"1997","unstructured":"Zipursky A, Brown E, Christensen H, Sutherland R, Doyle J. Leukemia and\/or myeloproliferative syndrome in neonates with Down syndrome. Semin Perinatol. 1997;21:97\u2013101.","journal-title":"Semin Perinatol"},{"key":"312_CR19","first-page":"569","volume":"65","author":"M Adam","year":"2007","unstructured":"Adam M, Vincenot A, Gouraud F, et al. Transient myeloproliferative disorder in a neonate without Down syndrome. Ann Biol Clin (Paris). 2007;65:569\u201373.","journal-title":"Ann Biol Clin (Paris)"},{"key":"312_CR20","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng955","volume":"32","author":"J Wechsler","year":"2002","unstructured":"Wechsler J, Greene M, McDevitt MA, et al. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat Genet. 2002;32:148\u201352.","journal-title":"Nat Genet"},{"key":"312_CR21","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/ng1566","volume":"37","author":"Z Li","year":"2005","unstructured":"Li Z, Godinho FJ, Klusmann JH, Garriga-Canut M, Yu C, Orkin SH. Developmental stage selective effect of somatically mutated leukemogenic transcription factor GATA1. Nat Genet. 2005;37:613\u20139.","journal-title":"Nat Genet"},{"key":"312_CR22","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1182\/blood-2005-02-0551","volume":"106","author":"AG Muntean","year":"2005","unstructured":"Muntean AG, Crispino JD. Differential requirements for the activation domain and FOG-interaction surface of GATA-1 in megakaryocyte gene expression and development. Blood. 2005;106:1223\u201331.","journal-title":"Blood"},{"key":"312_CR23","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2141.2004.05342.x","volume":"128","author":"E Carpenter","year":"2005","unstructured":"Carpenter E, Valverde-Garduno V, Sternberg A, Mitchell C, Roberts I, Vyas R. GATA1 mutation and trisomy 21 are required only in haematopoietic cells for development of transient myeloproliferative disorder. Br J Haematol. 2005;128:548\u201351.","journal-title":"Br J Haematol"},{"key":"312_CR24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1182\/blood-2003-05-1556","volume":"103","author":"S Gurbuxani","year":"2004","unstructured":"Gurbuxani S, Vyas P, Crispino JD. Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome. Blood. 2004;103:399\u2013406.","journal-title":"Blood"},{"key":"312_CR25","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/01.mph.0000212997.02554.f6","volume":"28","author":"G Xu","year":"2006","unstructured":"Xu G, Kato K, Toki T, Yoshihiro T, Kiminori T, Ito E. Development of acute megakaryoblastic leukemia from a minor clone in a Down syndrome patient with clinically overt transient myeloproliferative disorder. J Pediatr Hematol Oncol. 2006;28:696\u20138.","journal-title":"J Pediatr Hematol Oncol"},{"key":"312_CR26","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1182\/blood-2008-05-157859","volume":"112","author":"ST Chou","year":"2008","unstructured":"Chou ST, Opalinska JB, Yao Y, et al. Trisomy 21 enhances human fetal erythro-megakaryocytic development. Blood. 2008;112:4503\u20136.","journal-title":"Blood"},{"key":"312_CR27","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1046\/j.1365-2141.2002.03756.x","volume":"118","author":"B Stark","year":"2002","unstructured":"Stark B, Jeison M, Preudhomme C, et al. Acquired trisomy 21 and distinct clonal evolution in acute megakaryoblastic leukaemia in young monozygotic twins. Br J Haematol. 2002;118:1082\u20136.","journal-title":"Br J Haematol"},{"key":"312_CR28","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1182\/blood-2002-11-3599","volume":"102","author":"L Rainis","year":"2003","unstructured":"Rainis L, Bercovich D, Strehl S, et al. Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21. Blood. 2003;102:981\u20136.","journal-title":"Blood"},{"key":"312_CR29","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1182\/blood-2007-01-069542","volume":"110","author":"SR Pine","year":"2007","unstructured":"Pine SR, Guo Q, Yin C, Jayabose S, Druschel CM, Sandoval C. Incidence and clinical implications of GATA1 mutations in newborns with Down syndrome. Blood. 2007;110:2128\u201331.","journal-title":"Blood"},{"key":"312_CR30","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.leukres.2008.02.010","volume":"32","author":"MG Shin","year":"2008","unstructured":"Shin MG, Choi HW, Kim HR, et al. Tetrasomy 21 as a sole acquired abnormality without GATA1 gene mutation in pediatric acute megakaryoblastic leukemia: a case report and review of the literature. Leuk Res. 2008;32:1615\u20139.","journal-title":"Leuk Res"}],"container-title":["The Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-010-0312-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12098-010-0312-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-010-0312-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T03:56:48Z","timestamp":1559966208000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12098-010-0312-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,2]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["312"],"URL":"https:\/\/doi.org\/10.1007\/s12098-010-0312-x","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,2]]}}}